Implementation of advanced tools such as real-time biosensing, closed-loop control, and artificial intelligence-driven decision support systems may help address antimicrobial resistance.
Early Contributors to the Science of Blood Culture
Today, blood cultures are a commonplace, highly advanced, and often automated function in microbiology laboratories, but this was not always the case.
Challenges and Evolution in the Regulatory Environment for Cell and Gene Therapies
Since 2017, the FDA has quickly adjusted processes, expanded capabilities, and created new guidelines specifically for ATMPs to keep up with the pace of the industry and discover and penalize developers who do not abide by regulations.
Lessons Learned During The Pandemic: An Expert Discussion on Pharmaceutical Quality Control
Three ATMP experts recently discussed how the COVID-19 pandemic has impacted pharmaceutical quality control processes and the main takeaways for new ATMP developers.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...